Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Up 24.1% in March

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 2,940,000 shares, an increase of 24.1% from the February 28th total of 2,370,000 shares. Based on an average daily trading volume, of 807,300 shares, the short-interest ratio is presently 3.6 days. Approximately 5.0% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. KeyCorp upgraded shares of Health Catalyst from a "sector weight" rating to an "overweight" rating and set a $9.00 target price for the company in a research note on Wednesday, January 8th. Piper Sandler reduced their price objective on Health Catalyst from $12.00 to $8.00 and set an "overweight" rating on the stock in a research note on Tuesday, February 11th. Wells Fargo & Company decreased their price target on shares of Health Catalyst from $13.00 to $10.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Royal Bank of Canada dropped their price objective on shares of Health Catalyst from $7.00 to $6.00 and set a "sector perform" rating for the company in a research report on Thursday, February 27th. Finally, Stephens decreased their price objective on Health Catalyst from $7.00 to $5.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 6th. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Health Catalyst presently has an average rating of "Moderate Buy" and a consensus target price of $9.27.

Remove Ads

Insider Transactions at Health Catalyst

In other Health Catalyst news, COO Daniel Lesueur sold 16,902 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $4.52, for a total transaction of $76,397.04. Following the completion of the transaction, the chief operating officer now directly owns 216,250 shares in the company, valued at $977,450. This represents a 7.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Linda Llewelyn sold 6,441 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $5.43, for a total transaction of $34,974.63. Following the completion of the sale, the insider now owns 85,819 shares in the company, valued at $465,997.17. This represents a 6.98 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 56,530 shares of company stock valued at $299,572. Corporate insiders own 2.50% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in HCAT. Point72 Asset Management L.P. boosted its stake in shares of Health Catalyst by 69.4% during the 3rd quarter. Point72 Asset Management L.P. now owns 516,934 shares of the company's stock worth $4,208,000 after buying an additional 211,805 shares during the last quarter. Impax Asset Management Group plc boosted its position in Health Catalyst by 7.7% during the fourth quarter. Impax Asset Management Group plc now owns 2,750,000 shares of the company's stock valued at $19,442,000 after purchasing an additional 195,525 shares during the last quarter. Geode Capital Management LLC grew its stake in Health Catalyst by 4.9% in the third quarter. Geode Capital Management LLC now owns 1,443,036 shares of the company's stock valued at $11,749,000 after purchasing an additional 66,896 shares in the last quarter. State Street Corp grew its stake in Health Catalyst by 2.5% in the third quarter. State Street Corp now owns 1,163,754 shares of the company's stock valued at $9,473,000 after purchasing an additional 28,251 shares in the last quarter. Finally, Virtu Financial LLC acquired a new position in shares of Health Catalyst during the 4th quarter worth approximately $110,000. Institutional investors own 85.00% of the company's stock.

Health Catalyst Stock Down 3.1 %

Shares of HCAT traded down $0.13 during mid-day trading on Friday, hitting $4.01. 940,054 shares of the company's stock were exchanged, compared to its average volume of 616,902. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. Health Catalyst has a 52 week low of $3.72 and a 52 week high of $9.24. The company has a market cap of $281.55 million, a PE ratio of -2.97 and a beta of 1.43. The company has a 50-day simple moving average of $4.89 and a 200 day simple moving average of $6.72.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.